Paul C. Grint
2014 - Regulus Therapeutics
In 2014, Paul C. Grint earned a total compensation of $2.6M as President & Chief Executive Officer at Regulus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $82,973 |
|---|---|
| Option Awards | $2,290,597 |
| Salary | $195,271 |
| Other | $1,851 |
| Total | $2,570,692 |
Grint received $2.3M in option awards, accounting for 89% of the total pay in 2014.
Grint also received $83K in non-equity incentive plan, $195.3K in salary and $1.9K in other compensation.
Rankings
In 2014, Paul C. Grint's compensation ranked 3,547th out of 13,032 executives tracked by ExecPay. In other words, Grint earned more than 72.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,547 out of 13,032 | 73rd |
Division Manufacturing | 1,247 out of 4,965 | 75th |
Major group Chemicals And Allied Products | 406 out of 1,690 | 76th |
Industry group Drugs | 314 out of 1,369 | 77th |
Industry Pharmaceutical Preparations | 255 out of 1,042 | 76th |
Source: SEC filing on April 22, 2016.
Grint's colleagues
We found three more compensation records of executives who worked with Paul C. Grint at Regulus Therapeutics in 2014.